Uses of indolinone compounds
US11285132B2 · kind B2 · utility
1Cited by
14References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 13, 2020 |
| Grant date | Mar 29, 2022 |
| Priority date | — |
| Expiry date | Apr 13, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/73
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and compositions for treating acute myeloid leukemia and diffuse large B cell lymphoma using combinations of venetoclax and indolinone derivatives are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.